NanoViricides, Inc.
NNVC · AMEX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $21 | $22 | $13 | $22 |
| - Cash | $2 | $5 | $8 | $14 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $20 | $17 | $5 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$9 | -$7 | -$8 | -$7 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$8 | -$9 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.63 | -0.7 | -0.74 | -0.7 |
| % Growth | 10% | 5.4% | -5.7% | – |
| Operating Cash Flow | -$8 | -$6 | -$6 | -$6 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$9 | -$6 | -$6 | -$6 |